Energy News / Shareholders Foundation, Inc.

NYSE:ARA Long Term Shareholder Notice: Investigation of Potential Wrongdoing at American Renal Associates Holdings, Inc.

Via: ReleaseWire

Updated 11:15 AM CDT, Wed, July 24,2019

An investigation on behalf of current long term investors in American Renal Associates Holdings, Inc. (NYSE: ARA) shares over possible breaches of fiduciary duty by certain officers and directors was announced..

San Diego, CA -- (SBWIRE) -- 07/24/2019 -- An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of American Renal Associates Holdings, Inc. was announced.

Investors who are current investors in American Renal Associates Holdings, Inc. (NYSE: ARA) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm for investors in NYSE: ARA stocks follows a lawsuit filed against American Renal Associates Holdings, Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NYSE: ARA stocks, concerns whether certain American Renal Associates Holdings directors are liable in connection with the allegations made in that lawsuit.

The plaintiff alleges that the defendants violated Federal Securities Laws.

Beverly, MA based American Renal Associates Holdings, Inc. operates as a dialysis services provider in the United States.

American Renal Associates Holdings, Inc. reported that its annual Total Revenue declined from $749.76 million in 2016 to $745.1 million in 2017 and that its Net Loss of $0.385 million in 2016 turned into a Net Income of $4.85 million in 2017.

Shares of American Renal Associates Holdings, Inc. (NYSE: ARA) reached $23.49 per share on October 1, 2018.

On March 8, 2019, American Renal Associates Holdings, Inc. announced it would delay the filing of its earnings report for the fiscal year ended December 31, 2018 as it continues to examine reserve computations and other accounting practices that may have an impact on the company's accounts receivable and revenue for fiscal year 2018, as well as previously reported fiscal years ranging from 2014 through 2017.

Those who purchased shares of American Renal Associates Holdings, Inc. (NYSE: ARA) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

For more information on this press release visit:
http://www.sbwire.com/press-releases/nyseara-long-term-shareholder-notice-investigation-of-potential-wrongdoing-at-american-renal-associates-holdings-inc-1249431.htm

Media Relations Contact
Michael Daniels
1-858-779-1554
Email: Click to Email Michael Daniels
Web: http://www.ShareholdersFoundation.com